Are CMND insiders buying or selling?

In the last 90 days, Clearmind (CMND) had 0 insider transactions. Track every executive trade, dollar amount, and date.

Which hedge funds own CMND?

See every hedge fund and asset manager holding Clearmind (CMND).

How much of CMND trades in dark pools?

Track Clearmind (CMND) dark pool activity and off-exchange block trades.

Clearmind (CMND) — 54.8% Short — Squeeze Watch

Also trades as: CMND.CN (CNQ) · $vol 0M

$0.25

+0.02 (+6.64%)

Weekly Expected Move ±35.0%

$0 $0 $1 $1 $1

NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 25 · $34438 mcap · 101572 float · 5972.87% daily turnover · Short 44% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Smart Money Score

Watch 25

Insider—

Congress—

ETF Holdings—

Key Statistics

Market Cap$0.0M

52W Range0.22-52.4

Volume1,917,121

Avg Volume6,066,767

Beta-1.12

Dividend—

Analyst Ratings

No analyst coverage

Company Info

CEOAdi Zuloff-Shani

Employees4

SectorHealthcare

IndustryBiotechnology

IPO Date2022-11-15

Websiteclearmindmedicine.com

1220 West 6th Avenue
Vancouver, BC V6H 1A5
CA

604 260 1566

About Clearmind Medicine Inc.

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Latest News